Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection

Understanding the impact of prior infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the response to vaccination is a priority for responding to the coronavirus disease 2019 (COVID-19) pandemic. In particular, it is necessary to understand how prior infection plus vaccina...

Descripción completa

Detalles Bibliográficos
Autores principales: Urbanowicz, Richard A., Tsoleridis, Theocharis, Jackson, Hannah J., Cusin, Lola, Duncan, Joshua D., Chappell, Joseph G., Tarr, Alexander W., Nightingale, Jessica, Norrish, Alan R., Ikram, Adeel, Marson, Ben, Craxford, Simon J., Kelly, Anthony, Aithal, Guruprasad P., Vijay, Amrita, Tighe, Patrick J., Ball, Jonathan K., Valdes, Ana M., Ollivere, Benjamin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835846/
https://www.ncbi.nlm.nih.gov/pubmed/34376569
http://dx.doi.org/10.1126/scitranslmed.abj0847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835846/
https://www.ncbi.nlm.nih.gov/pubmed/34376569
http://dx.doi.org/10.1126/scitranslmed.abj0847

Ejemplares similares